폐암.
Scientists map proteins that let carcinomas change identity
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
Researchers at Cold Spring Harbor Laboratory have identified key proteins and protein complexes that help certain carcinomas shift their cellular identity and potentially evade treatment. Two new studies, focusing on pancreatic cancer and tuft cell lung cancer, highlight molecular structures that could become targets for more precise and selective therapies.
한 연구에 따르면, 진행성 폐암 환자가 하루 중 일찍 면역화학요법을 받으면 생존 기간이 더 길다. 홍콩 의료 전문가는 이 발견이 최적 치료 시간을 모색할 가능성을 열었으나 더 많은 연구가 필요하다고 말했다. 이 연구는 중국 본토 후난 암병원의 학자들이 주도했으며 홍콩 중문대 의학부가 지원했다.
AI에 의해 보고됨
Researchers in Japan have uncovered how cancer cells use tiny vesicles to spread the immune-suppressing protein PD-L1, explaining why immunotherapy often fails. A protein called UBL3 directs this process, but common statins can disrupt it, potentially boosting treatment effectiveness. The findings, from patient samples and lab tests, suggest a simple way to improve outcomes for lung cancer patients.
Researchers have identified a novel protein biomarker that detects lung cancer at an early stage with high accuracy. The discovery, detailed in a recent study, could enhance screening methods and improve patient outcomes. Clinical trials showed promising results in identifying the disease before symptoms appear.